Evaluation of cardiac implantable electronic device lead parameters before and after radiotherapy
Pacing and Clinical Electrophysiology · 2024-09 · 47 (9) · 1176-1184
DOI: 10.1111/pace.15048 ↗At a glance
Journal article in Pacing and Clinical Electrophysiology, published online on 2024-07-30. Written by Mia Bang Larsen and 5 co-authors. Institution: Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Major MEDLINE topics: Defibrillators, Implantable, Pacemaker, Artificial. Cited 5 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Introduction and aim Radiotherapy in cancer patients with a pacemaker or an implantable cardioverter defibrillator might damage the device and possibly result in malfunction of the device. We aimed to examine device malfunction and change in lead parameters in this group.
Methods
The medical records of pacemaker/implantable cardioverter defibrillator patients who underwent radiotherapy at Aalborg University Hospital between July 1, 2016, and June 30, 2021, were reviewed. Treatment was planned according to risk of device malfunction, assessed using local guidelines. Bootstrap linear regression was used to identify possible differences in lead parameters depending on beam energy and anatomical location.
Results
One hundred nine patients with a pacemaker/implantable cardioverter defibrillator who received a total of 122 radiotherapy courses in the study period were identified. No device malfunctions or significant changes in lead parameters during radiotherapy were observed. Only the left ventricle lead threshold and impedance were found to be significantly different when compared by beam energy; however, these changes were relatively small and unlikely to be of clinical relevance.
Conclusion
No device malfunction or clinically relevant changes in lead parameters were identified in this study, suggesting that radiotherapy of pacemaker/implantable cardioverter defibrillator patients can be regarded as safe when following relevant safety precautions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Medical Physics, Oncology Department, Aalborg University Hospital, Aalborg, Denmark.
- Unit of Clinical Biostatistics, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID profiles: Mia Bang Larsen, Sam Riahi
Cite
APA
Larsen, M. B., Jakobsen, A. R., Lundbye-Christensen, S., Riahi, S., Thøgersen, A. M., & Zaremba, T. (2024). Evaluation of cardiac implantable electronic device lead parameters before and after radiotherapy. Pacing and Clinical Electrophysiology, 47(9), 1176-1184. https://doi.org/10.1111/pace.15048
Vancouver
Larsen MB, Jakobsen AR, Lundbye-Christensen S, Riahi S, Thøgersen AM, Zaremba T. Evaluation of cardiac implantable electronic device lead parameters before and after radiotherapy. Pacing and Clinical Electrophysiology. 2024;47(9):1176-1184. doi:10.1111/pace.15048
BibTeX
@article{Larsen2024,
author = {Larsen, Mia Bang and Jakobsen, Annette Ross and Lundbye-Christensen, Søren and Riahi, Sam and Thøgersen, Anna Margrethe and Zaremba, Tomas},
title = {Evaluation of cardiac implantable electronic device lead parameters before and after radiotherapy},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
volume = {47},
number = {9},
pages = {1176--1184},
doi = {10.1111/pace.15048}
}
EUVIMED